Prosecution Insights
Last updated: August 06, 2026

Acuity Law Group, P.C.

25 pending office actions • 19 clients • 25 examiners • 20 art units • 0 of 25 (0%) have an AI response strategy ready

Quality Metrics (n=1916 apps, methodology: how we score firms)

79.9%
Allowance Rate
n=1916
+0.93σ
Allowance Rate (norm)
n=1916
4.2
OAs to Allowance
n=801
+0.06σ
OAs to Allow (norm)
n=801
1400 days
Time to Allowance
n=801
+16.1pp
Interview Lift
n=1916
29.1%
RCE Rate
n=1916
5.0%
Appeal Rate
n=1916

Rejection Performance (% of received rejections ultimately overcome)

87.2%
§101 Overcome
n=204
83.3%
§102 Overcome
n=330
82.8%
§103 Overcome
n=587
84.7%
§112 Overcome
n=607

Specialization & Scale

A61K, G01N, A61B
Top CPC Subclasses
33%
Top-3 CPC Share
n=1916
1
Practitioners
n=1916
1916.0
Apps / Practitioner
n=1916

Portfolio Summary

25
Total Pending OAs
16
Non-Final OAs
8
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 12 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
0
Due this week
6
Due this month
0
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 12 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)Due ≤ 30 days (6)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

12
Hard (48%)
9
Medium (36%)
4
Easy (16%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (4%)
§103 only6 (24%)
§102 only1 (4%)
§112 only3 (12%)
Double-patenting only1 (4%)
Double-patenting + other2 (8%)
Multi-statute (no §101)11 (44%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

17
Life Sciences
68% of docket
1
Information Tech
4% of docket
0
Communications
0% of docket
1
Semiconductors
4% of docket
3
Mechanical / Eng
12% of docket
3
Business / Other
12% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

250 h
Manual time on pending OAs
50 h
Time saved (low, 20%)
88 h
Time saved (mid, 35%)
2.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KOHLER, STEPHANIE A 1 31.7% +31.1%
STULII, VERA 1 32.6% +24.8%
SONG, HOSUK 1 94.7% +2.8%
KAUR, GURPREET 1 65.1% +36.2%
HAGHIGHATIAN, MINA 1 45.7% +39.8%
KIM, YOUNG J 1 64.8% +18.0%
GEDEON, BRIAN T 1 87.1% +6.9%
DEKARSKE, MADELINE MCGUIRE 1 0.0% +0.0%
WILSON, JERICA KATLYNN 1 61.5% +38.7%
GWARTNEY, ELIZABETH A 1 36.3% +35.1%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
19025540 MULTI FACTOR AUTHENTICATION SONG, HOSUK
18642557 BODY-WORN VITAL SIGN MONITOR GEDEON, BRIAN T

Hard Cases (12)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18036123 TEST DEVICE AND TEST PAPER JARRETT, LORE RAMILLANO 97d overdue
17617190 SYSTEM AND METHOD FOR REAL-TIME MULTICOLOR SHORTWAVE INFRARED FLUORESCENCE IMAGING FAYE, MAMADOU 74d overdue
18252489 LOOP MEDIATED ISOTHERMAL NUCLEIC ACID AMPLIFICATION (LAMP) USING LNA-MODIFIED PRIMERS AND A METAL-BASED COLORIMETRIC METHOD FOR DETECTING AN AMPLIFICATION PRODUCT YU, TIAN NMN 17d overdue
19305630 METHOD OF PRODUCING A FLAVOR COMPOSITION STULII, VERA 10d overdue
18443904 MEK-INHIBITOR FOR THE TREATMENT OF VIRAL AND BACTERIAL INFECTIONS WILSON, JERICA KATLYNN 23d
19312196 FLAVOR COMPOSITION KOHLER, STEPHANIE A
18852335 METHODS AND COMPOSITIONS FOR POTENTIATION OF A LIGAND HAGHIGHATIAN, MINA
18693887 AUTOTAXIN-INHIBITORS DEKARSKE, MADELINE MCGUIRE

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
19305630 METHOD OF PRODUCING A FLAVOR COMPOSITION STULII, VERA 10d overdue
18443904 MEK-INHIBITOR FOR THE TREATMENT OF VIRAL AND BACTERIAL INFECTIONS WILSON, JERICA KATLYNN 23d
19312196 FLAVOR COMPOSITION KOHLER, STEPHANIE A
18866963 BIOSENSOR AND METHOD FOR PREPARING BIOSENSOR KAUR, GURPREET
18852335 METHODS AND COMPOSITIONS FOR POTENTIATION OF A LIGAND HAGHIGHATIAN, MINA
18711585 WHOLE GENOME CPG ANALYSIS KIM, YOUNG J
18579268 FLAVOR COMPOSITION GWARTNEY, ELIZABETH A

Client Portfolio (19 clients)

Top Art Units

Art UnitApps
17912
16712
24351
37961
16221
16211
17591
16251
16411
16351

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19312196 FLAVOR COMPOSITION Planet A Foods GmbH KOHLER, STEPHANIE A 1791 §103§112Other Final Rejection Pending Aug 27, 2025
19305630 METHOD OF PRODUCING A FLAVOR COMPOSITION Planet A Foods GmbH STULII, VERA 1791 §102§103§112 Final Rejection 10d overdue Pending Aug 20, 2025
19025540 MULTI FACTOR AUTHENTICATION Coronet Cyber Security Ltd. SONG, HOSUK 2435 DP Final Rejection Pending Jan 16, 2025
18866963 BIOSENSOR AND METHOD FOR PREPARING BIOSENSOR Leadway (Hk) Limited KAUR, GURPREET §102 Non-Final OA Pending Nov 18, 2024
18852335 METHODS AND COMPOSITIONS FOR POTENTIATION OF A LIGAND National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government HAGHIGHATIAN, MINA §102§103§112Other Non-Final OA Pending Sep 27, 2024
18711585 WHOLE GENOME CPG ANALYSIS Nucleix Ltd. KIM, YOUNG J §103 Non-Final OA Pending May 18, 2024
18642557 BODY-WORN VITAL SIGN MONITOR Sotera Wireless, Inc. GEDEON, BRIAN T 3796 DPOther Non-Final OA Pending Apr 22, 2024
18693887 AUTOTAXIN-INHIBITORS Universitaet Muenster DEKARSKE, MADELINE MCGUIRE 1622 §101§102§103§112 Non-Final OA Pending Mar 20, 2024
18443904 MEK-INHIBITOR FOR THE TREATMENT OF VIRAL AND BACTERIAL INFECTIONS Atriva Therapeutics GmbH WILSON, JERICA KATLYNN 1621 §103§112Other Non-Final OA 23d Pending Feb 16, 2024
18579268 FLAVOR COMPOSITION Planet A Foods GmbH GWARTNEY, ELIZABETH A 1759 §102§112 Non-Final OA Pending Jan 12, 2024
18559019 TOPICAL NAPROXEN FORMULATIONS AND THEIR USE Smartech Topical, Inc. BELL, SARA ELIZABETH 1625 §103§112DP Non-Final OA Pending Nov 03, 2023
18236327 T CELL RECEPTORS AND USES THEREOF Medigene Immunotherapies GmbH DIBRINO, MARIANNE 1641 §112 Non-Final OA 9d Pending Aug 21, 2023
18264046 SOLE USE OF POLYMERSOME ASSOCIATED ADJUVANT FOR STIMULATING AN IMMUNE RESPONSE Acm Biolabs Pte. Ltd. YU, DAVID TUYANG 1635 §102§103§112 Non-Final OA Pending Aug 02, 2023
18262441 APPLICATION OF PERMITTIVITY MEASUREMENT PROBES IN AN SUSPENSION CULTURE AGGREGATE COMPRISING CELL AGGREGATES Repairon GmbH JOHNSON, KARA D 1632 §103§112 Final Rejection Pending Jul 21, 2023
18262433 METHOD OF CHANGING CULTURE MEDIUM OF A CULTURE USING SPINFILTERS Repairon GmbH MARTIN, PAUL C 1653 §103 Final Rejection 19d Pending Jul 21, 2023
18252489 LOOP MEDIATED ISOTHERMAL NUCLEIC ACID AMPLIFICATION (LAMP) USING LNA-MODIFIED PRIMERS AND A METAL-BASED COLORIMETRIC METHOD FOR DETECTING AN AMPLIFICATION PRODUCT Multiplexdx, S.R.O. YU, TIAN NMN 1681 §102§103§112 Non-Final OA 17d overdue Pending May 10, 2023
18036123 TEST DEVICE AND TEST PAPER Leadway (Hk) Limited JARRETT, LORE RAMILLANO 1797 §103§112 Final Rejection 97d overdue Pending May 09, 2023
18144244 COMPOSITION AND METHODS FOR SENSITIVE MOLECULAR ANALYSIS Trust Bio-Sonics, Inc. LI, JOHN DENNY 3798 §112 Non-Final OA Pending May 08, 2023
18092420 METHODS AND COMPOSITIONS FOR INCREASING EFFICIENCY OF TARGETED GENE MODIFICATION USING OLIGONUCLEOTIDE-MEDIATED GENE REPAIR Cibus Europe B.V. BOGGS, RUSSELL T 1663 §103Other Final Rejection 28d Pending Jan 02, 2023
17997009 METHOD FOR DETECTING HBV GENOTYPE, OLIGONUCLEOTIDE AND KIT Leadway (Hk) Limited PARKIN, JEFFREY S 1671 §103 Non-Final OA 30d overdue Pending Oct 24, 2022
17874198 FLEXIBLE SELF-POWERED MATERIALS FOR ON DEMAND GENERATION OF HYDROGEN PEROXIDE Wesbot, LLC EVANISKO, GEORGE ROBERT 3792 §103 Non-Final OA 71d Pending Jul 26, 2022
17700356 METHOD AND DEVICE FOR PRODUCING OPTIMIZED LIPID-BASED MICRO/NANO-BUBBLES Trust Bio-Sonis Inc. HOWELL, MARC C 1618 §103§112 Non-Final OA Pending Mar 21, 2022
17631845 A METHOD OF ELICITING AN IMMUNE RESPONSE BY ADMINISTERING A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ANTIGEN TOGETHER WITH A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ADJUVANT AS WELL AS COMPOSITIONS COMPRISING THE TWO POPULATIONS OF POLYMERSOMES Acm Biolabs Pte. Ltd. FOLEY, SHANON A 1671 §103 Final Rejection 30d Pending Jan 31, 2022
17576109 ANTI-SIRP ALPHA ANTIBODIES Sairopa B.V. BRISTOL, LYNN ANNE 1643 §112 Non-Final OA 9d Pending Jan 14, 2022
17617190 SYSTEM AND METHOD FOR REAL-TIME MULTICOLOR SHORTWAVE INFRARED FLUORESCENCE IMAGING The Regents of the University of California FAYE, MAMADOU 2884 §103§112 Non-Final OA 74d overdue Pending Dec 07, 2021

Managing Acuity Law Group, P.C.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month